Treatment of typhid
Reading File
Finding Sources
Searching PubMed
"typhoid fever"[MeSH Terms] AND "drug therapy"[MeSH Terms]
Finding Sources
Searching PubMed
"typhoid fever" AND "antibiotic" AND "treatment"
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive data from Harrison's (2025), Tintinalli's, Park's, and Sleisenger's. Let me compile the full answer.
Treatment of Typhoid Fever (Enteric Fever)
Typhoid fever (caused by Salmonella enterica serotype Typhi, and paratyphoid by S. Paratyphi A/B/C) requires prompt antibiotic therapy. Untreated, mortality reaches 10-30%; with appropriate treatment it falls to <1%.
Antibiotic Therapy
The choice of antibiotic depends heavily on the susceptibility pattern of the infecting strain, which varies by geographic region.
Empirical Treatment (Before Susceptibility Known)
| Agent | Dose | Route | Duration |
|---|---|---|---|
| Ceftriaxone | 2 g/day | IV | 10-14 days |
| Ciprofloxacin | 500 mg twice daily | PO | 5-7 days |
| Azithromycin | 1 g/day | PO | 10 days |
(Harrison's Principles of Internal Medicine 22E, 2025, Table 171-1)
By Susceptibility Pattern
1. Fully Susceptible Strains
- Optimal: Ceftriaxone 2 g/day IV (10-14 days) OR ciprofloxacin 500 mg PO twice daily (5-7 days)
- Alternatives: Azithromycin 1 g/day x 5 days, amoxicillin 1 g three times daily x 14 days, chloramphenicol 25 mg/kg three times daily x 14-21 days, or TMP-SMX 160/800 mg twice daily x 7-14 days
2. Multidrug-Resistant (MDR) Strains (resistant to chloramphenicol, ampicillin, TMP-SMX)
- Optimal: Ceftriaxone (IV) OR ciprofloxacin (if susceptible) OR azithromycin
- Note: Oral cefixime (15 mg/kg/day, 5-7 days) is an alternative but may have slightly higher clinical failure rates and longer time to defervescence vs. fluoroquinolones
3. Decreased Fluoroquinolone Susceptibility (DSC) / Fluoroquinolone-Resistant Strains (common on Indian subcontinent, South & Southeast Asia, parts of Africa)
- Preferred: Ceftriaxone IV or azithromycin PO
- Fluoroquinolones should not be used as first-line in travelers returning from South Asia due to the H58 clone with decreased ciprofloxacin susceptibility
4. Extensively Drug-Resistant (XDR) Strains (plasmid-mediated ESBL; dominant in Pakistan since 2016)
- Resistant to chloramphenicol, ampicillin, TMP-SMX, fluoroquinolones, and third-generation cephalosporins
- Consider: Carbapenems, azithromycin (if susceptible), or newer agents per susceptibility testing
- Azithromycin resistance has also been emerging in countries using it as first-line
(Harrison's 22E, 2025; Park's Textbook of Preventive & Social Medicine)
Dosage Summary Table (Park's - Uncomplicated Typhoid)
| Susceptibility | Optimal Antibiotic | Dose (mg/kg/day) | Days | Alternative | Dose (mg/kg/day) | Days |
|---|---|---|---|---|---|---|
| Fully sensitive | Fluoroquinolone (ofloxacin/ciprofloxacin) | 15 | 5-7 | Chloramphenicol / Amoxicillin / TMP-SMX | 50-75 / 75-100 / 8-40 | 14-21 / 14 / 14 |
| MDR | Fluoroquinolone or cefixime | 15 / 15 | 5-7 | Azithromycin / Ceftriaxone | - | - |
Severe / Complicated Typhoid
- Add dexamethasone if the patient is severely ill (e.g., with typhoid meningitis/encephalitis, shock, or altered consciousness):
- 8 mg/kg x 1 dose, then 1 mg/kg every 6 hours for 48 hours (IV)
- Alternative: Hydrocortisone 100 mg/day for 3-4 days in profoundly toxic patients
- Use IV ceftriaxone as the antibiotic backbone in severe disease
(Sleisenger & Fordtran's GI & Liver Disease; Tintinalli's Emergency Medicine; Park's)
Chronic Carrier Treatment
Carriers harbor the organism in the biliary tract (often with gallstones/chronic cholecystitis):
- Ampicillin or amoxicillin 4-6 g/day + Probenecid 2 g/day for 6 weeks (achieves ~70% eradication)
- Chloramphenicol is ineffective for clearing the carrier state
- Cholecystectomy combined with ampicillin therapy may be required for gallstone-associated carriers
(Park's Textbook of Preventive & Social Medicine)
Supportive Care
- IV fluid rehydration (especially in severe/diarrheal cases)
- Blood transfusion if significant GI blood loss
- Antipyretics (paracetamol preferred)
- Bowel perforation (a life-threatening complication) requires surgical management
Key Resistance Points to Remember
- MDR typhoid (resistant to chloramphenicol, ampicillin, TMP-SMX) - now very common; these three drugs are largely unreliable empirically
- DSC/Fluoroquinolone-resistant strains - high prevalence on the Indian subcontinent; fluoroquinolone monotherapy is risky in travelers from South Asia
- XDR typhoid (Pakistan dominant since 2016) - ESBL-producing; extremely limited options
- Azithromycin resistance is emerging in areas of heavy use - sensitivity testing is important
A 2022 systematic review of 27 RCTs (cited in Harrison's 22E) found no significant difference in treatment failure, relapse, or adverse events between ceftriaxone, fluoroquinolone, and azithromycin for susceptible strains - so all three remain valid choices when susceptibility is confirmed.
This is a shared conversation. Sign in to Orris to start your own chat.